Paul Gray Parker - Dec 31, 2021 Form 4 Insider Report for CLOROX CO /DE/ (CLX)

Role
Director
Signature
By Cheryl Brice, Attorney-in-Fact for
Stock symbol
CLX
Transactions as of
Dec 31, 2021
Transactions value $
$6,277
Form type
4
Date filed
1/4/2022, 03:19 PM
Previous filing
Oct 4, 2021
Next filing
Apr 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLX Common Stock Award $6.28K +36 +33.96% $174.36 142 Dec 31, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLX Deferred Stock Units Award $0 +919 $0.00 919 Dec 31, 2021 Common Stock 919 Direct F2, F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Receipt of Common Stock in lieu of portion of quarterly director's fee.
F2 1-for-1
F3 Annual award of Deferred Stock Units pursuant to the 2005 Stock Incentive Plan.
F4 The Deferred Stock Units will be settled 100% in Clorox stock in connection with the reporting person's retirement or other termination of service as a Director.